KIMBERLY MCFEE: Open Payments
NPI 1720624182 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 67 payments from 27 companies in 2025. Trend: 2023 $240 · 2024 $808 · 2025 $1,506
Food & beverage: $1,406Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $183 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| Daiichi Sankyo Inc. | 6 | $141 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| PUMA BIOTECHNOLOGY, INC. | 4 | $81 |
| ARRAY BIOPHARMA INC | 4 | $79 |
| Gilead Sciences, Inc. | 3 | $67 |
| PharmaEssentia USA Corporation | 3 | $60 |
| Azurity Pharmaceuticals, Inc. | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
Products named: Enhertu, IMFINZI, DARZALEX, NERLYNX, Trodelvy, BESREMI, BRAFTOVI, DANZITEN.
Industry payments across IA — which companies pay providers there.
